April 27th 2025
New research explores the complex relationship between female infertility and gynecological cancers, revealing minimal links and emphasizing the need for further studies.
Dr Rachel Dalthorp: Addressing Barriers in Postpartum Depression Treatment
June 24th 2024With an effective therapy available for treating postpartum depression, Rachel Dalthorp, MD, believes health care providers need to focus on educating patients and helping them navigate the health system so zuranolone can reach those who need it.
Watch
AxSpA Treatment Intensification in Practice Linked With Higher ASDAS Cutoff Than Recommended
June 22nd 2024In the clinical practice setting, intensifying treatment for axial spondyloarthritis (axSpA) is associated with a higher Ankylosing Spondylitis Disease Activity Score (ASDAS) cutoff value than recommended, new research found.
Read More
Early Detection of PH May Be Key to Improving NSCLC Survival Rates
June 21st 2024This investigation sought to expand knowledge of the impact of comorbid pulmonary hypertension (PH) on diagnosed non–small cell lung cancer (NSCLC), using data from adult patients treated at military hospital facilities within the US.
Read More
Dr Rachel Dalthorp: Zuranolone Improves Access to Postpartum Depression Treatment
June 19th 2024"As a health care provider and as a psychiatrist, it's something that I think about first—instead of step therapy, when I have a patient with postpartum depression, this is what they need to be on," Rachel Dalthorp, MD, explains.
Watch
BrECADD Regimen Reaches “Unprecedently High” PFS for Patients With Hodgkin Lymphoma
June 18th 2024The treatment regimen not only significantly improved progression-free survival (PFS) for patients with advanced stage classic Hodgkin lymphoma but was also better tolerated compared with a 20-year-old regimen being used.
Read More
Link Between Skin Cancer and Immunosuppressants Needs Further Research
June 13th 2024At the 2024 American Society of Clinical Oncology annual meeting, an abstract presenting real-world data stressed the need for further research regarding the association between immunosuppressant medication and the development of skin cancer.
Read More
Gray Matter Atrophy in MS a Strong Indicator of Progression, Study Suggests
June 13th 2024A cross-sectional, prospective study found that gray matter atrophy was more prevalent in patients with more severe progressive multiple sclerosis (MS) compared with those with less severe progressive disease.
Read More
Case Reports: Managing DLBCL Associated With Papillary Thyroid Carcinoma
June 12th 2024Case reports and systematic review found the combination of surgery, chemotherapy, and radiotherapy can effectively manage diffuse large B-cell lymphoma (DLBCL) associated with papillary thyroid carcinoma.
Read More
CMS Innovation Center's Latest Moves: Embedding Equity Into Value-Based Care
June 12th 2024During the CMS Health Equity Conference, health care leaders shared groundbreaking strategies to integrate health equity into value-based care models, aiming to enhance patient outcomes and reduce costs.
Read More
Fighting for the Future of LGBTQ Pride at Rutgers
June 11th 2024Continuing with our Pride Month podcast series, in this episode we speak with Perry Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, and James F. Dougherty, VMD, MS, current member of Rutgers' Board of Governors.
Listen
Dr Amit Singal on the Improving Outlook for HCC and How to Choose Treatments
June 10th 2024Amit Singal, MD, medical director of the Liver Tumor Program at UT Southwestern Medical Center, discussed the current outlook for patients with hepatocellular carcinoma (HCC) and how to choose between therapies.
Read More